Haijiao Zhang received her Bachelor and Master of Medicine degree from Jilin University in China and then earning an MD at Hannover Medical School in Germany. She joined Dr. Jeffrey Tyner’s laboratory as a postdoc in 2015 .The focus of her research in the Tyner lab has been oncogenic signaling and drug resistance mechanisms associated with hematologic malignancies. Between 2018 and 2019, Dr. Zhang embarked on a year-long visiting scholar opportunity in Dr. Ravi Majeti’s laboratory at Stanford University. In 2021, Dr. Zhang established her laboratory in the Division of Oncological Science at OHSU to study chromosome and copy number aberrations and WT1 in leukemia.